The human microbiome is a growing area of therapeutic exploration, especially in the context of infectious and gastrointestinal diseases. The microbiome refers to the collective genomes of the 10-to-100 trillion micro-organisms in the human body that aid with metabolic processes, protect against pathogens and interact with the immune system.
The last of these functions underpins the relatively novel application of microbiome modulators in the field of oncology. There are...
Welcome to In Vivo
Create an account to read this article
Already a subscriber?